Trial Profile
A pilot study of low dose capecitabine for the treatment of gastrointestinal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Gastrointestinal cancer
- Focus Therapeutic Use
- 03 Dec 2015 New trial record